Reviews

Section Edited by Sandra Demaria, MD and Lawrence Fong, MD

Vaccines for immunoprevention of DNA mismatch repair deficient cancers

Alejandro Hernandez-Sanchez, Mark Grossman, Kevin Yeung, Shizuko S Sei, Steven Lipkin, Matthias Kloor

10.1136/jitc-2021-004416

June 22, 2022

iRECIST and atypical patterns of response to immuno-oncology drugs

Jorge Luis Ramon-Patino, Sabine Schmid, Sally Lau, Lesley Seymour, Pierre-Olivier Gaudreau, Janice Juan Ning Li, Penelope Ann Bradbury, Emiliano Calvo

10.1136/jitc-2022-004849

June 17, 2022

Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment

Lihong Wang, Louisa S Chard Dunmall, Zhenguo Cheng, Yaohe Wang

10.1136/jitc-2021-004167

May 31, 2022

Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells

Sainiteesh Maddineni, John L Silberstein, John B Sunwoo

10.1136/jitc-2022-004693

May 17, 2022

Time to evolve: predicting engineered T cell-associated toxicity with next-generation models

Emmanuel Donnadieu, Maik Luu, Miriam Alb, Brigitte Anliker, Silvia Arcangeli, Chiara Bonini, Biagio De Angelis, Rashmi Choudhary, David Espie, Anne Galy, Cam Holland, Zoltán Ivics, Chahrazade Kantari-Mimoun, Marie Jose Kersten, Ulrike Köhl, Chantal Kuhn, Bruno Laugel, Franco Locatelli, Ibtissam Marchiq, Janet Markman, Marta Angiola Moresco, Emma Morris, Helene Negre, Concetta Quintarelli, Michael Rade, Kristin Reiche, Matthias Renner, Eliana Ruggiero, Carmen Sanges, Hans Stauss, Maria Themeli, Jan Van den Brulle, Michael Hudecek, Monica Casucci

10.1136/jitc-2021-003486

May 16, 2022

Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

Sonia Guedan, Maik Luu, Delphine Ammar, Paula Barbao, Chiara Bonini, Philippe Bousso, Christian J Buchholz, Monica Casucci, Biagio De Angelis, Emmanuel Donnadieu, David Espie, Beatrice Greco, Richard Groen, Johannes B Huppa, Chahrazade Kantari-Mimoun, Bruno Laugel, Mary Mantock, Janet L Markman, Emma Morris, Concetta Quintarelli, Michael Rade, Kristin Reiche, Alba Rodriguez-Garcia, Juan Roberto Rodriguez-Madoz, Eliana Ruggiero, Maria Themeli, Michael Hudecek, Ibtissam Marchiq

10.1136/jitc-2021-003487

May 16, 2022

Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?

Syrine Abdeljaoued, Sara Arfa, Marie Kroemer, Myriam Ben Khelil, Angélique Vienot, Bruno Heyd, Romain Loyon, Alexandre Doussot, Christophe Borg

10.1136/jitc-2021-003472

April 25, 2022

JAK inhibitors and COVID-19

Gabriel Levy, Paola Guglielmelli, Peter Langmuir, Stefan Constantinescu

10.1136/jitc-2021-002838

April 22, 2022

Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology

Yanchen Zhou, Hweixian L Penny, Mark A Kroenke, Bianca Bautista, Kelly Hainline, Lynette S Chea, Jane Parnes, Daniel T Mytych

10.1136/jitc-2021-004225

April 20, 2022

Tumor-associated macrophages in multiple myeloma: advances in biology and therapy

Jennifer Sun, Chaelee Park, Nicole Guenthner, Shannon Gurley, Luna Zhang, Berit Lubben, Ola Adebayo, Hannah Bash, Yixuan Chen, Mina Maksimos, Barbara Muz, Abdel Kareem Azab

10.1136/jitc-2021-003975

April 15, 2022